Improving the quality of anti-emetic therapy

Kristin Ramm, Signe De Flon, Hroar Piene, Claes G. Tropé

    Research output: Contribution to journalArticle

    1 Scopus citations


    The outcome of anti-emetic therapy (AT) to women with gynaecological cancer receiving chemotherapy, in total 552 courses, was registered for a 1-year period. A quality improvement (QI) programme was established, based on three standardized AT regimens. Evaluation and documentation of AT effects were performed by the patients themselves, reporting the number of emetic episodes and degree of nausea for 5 days following the chemotherapeutic treatment. The results were visualized in monthly graphic displays. Various factors which might contribute to the achieved improvements are discussed. In conclusion, the continuous QI process seems to be a suitable method in guiding direct patient care.

    Original languageEnglish (US)
    Pages (from-to)37-40
    Number of pages4
    JournalInternational Journal for Quality in Health Care
    Issue number1
    StatePublished - Jan 1 1994


    • Anti-emetic therapy
    • Patient evaluation
    • Quality improvement.

    ASJC Scopus subject areas

    • Health Policy
    • Public Health, Environmental and Occupational Health

    Fingerprint Dive into the research topics of 'Improving the quality of anti-emetic therapy'. Together they form a unique fingerprint.

  • Cite this